Franck Fajnkuchen
Overview
Explore the profile of Franck Fajnkuchen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
412
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bourdin A, Cohen S, Nghiem-Buffet S, Smadja J, Paques M, Fajnkuchen F, et al.
Graefes Arch Clin Exp Ophthalmol
. 2025 Jan;
PMID: 39808276
Purpose: Intravitreal injections of anti-VEGF agents are considered as safe, with a very low rate of intraocular inflammations (IOI). Faricimab is a novel intravitreal bispecific antibody targeting both VEGF-A and...
2.
Torres-Villaros H, Timoumi R, Fajnkuchen F, Klokner A, Giocanti-Auregan A
Retina
. 2024 Aug;
44(11):1937-1944.
PMID: 39208410
Purpose: To assess macular thickness fluctuations and their association with visual acuity outcomes in eyes with diabetic macular edema treated with an intravitreal dexamethasone (DEX) implant. Methods: The SD of...
3.
Enjalbert A, Giocanti-Auregan A, Fajnkuchen F, Torres-Villaros H
Retina
. 2023 Nov;
44(4):572-580.
PMID: 38029421
Purpose: To analyze the changes in macular vascular densities (VDs) and foveal avascular zone (FAZ) over a 6-year period using swept-source optical coherence tomography angiography in patients with sickle cell...
4.
Giocanti-Auregan A, Fajnkuchen F
Case Rep Ophthalmol
. 2023 Apr;
14(1):159-164.
PMID: 37065727
Sickle cell proliferative retinopathy usually presents first in the peripheral retina and the ability to extend and enhance our visualization of the peripheral retina would allow for superior clinical decision-making....
5.
Glacet-Bernard A, Girmens J, Kodjikian L, Delcourt C, Fajnkuchen F, Creuzot-Garcher C, et al.
Ophthalmic Res
. 2023 Mar;
66(1):824-834.
PMID: 36972579
Introduction: Information about real-world ranibizumab use is needed to optimize treatment of macular edema secondary to retinal vein occlusion (RVO). The BOREAL-RVO study assessed treatment use, effectiveness, and safety of...
6.
Morel J, Fajnkuchen F, Amari F, Sritharan N, Bloch-Queyrat C, Giocanti-Auregan A
J Clin Med
. 2023 Feb;
12(4).
PMID: 36835902
: To follow the evolution of peripheral ischemia by fluorescein angiography (FA) on ultra-wide-field (UWF) images in diabetic patients treated with anti-vascular endothelial growth factor (anti-VEGF) for macular edema. :...
7.
Anjou M, Fajnkuchen F, Nabholz N, Nghiem-Buffet S, Mrejen S, Giocanti-Auregan A
Case Rep Ophthalmol
. 2022 Sep;
13(2):617-625.
PMID: 36160496
We described clinical and multimodal imaging findings in 4 patients with unilateral acute idiopathic maculopathy (UAIM) associated with hand, foot, and mouth disease. Four eyes of 4 patients (3 women...
8.
Torres-Villaros H, Fajnkuchen F, Amari F, Janicot L, Giocanti-Auregan A
J Clin Med
. 2022 Feb;
11(4).
PMID: 35207207
Sickle cell retinopathy (SCR) is classified by Goldberg based on peripheral vascular changes. Ultra-wide field (UWF) imaging has enhanced visualization of the peripheral retina. However, there is no consensus on...
9.
Chaher A, Fajnkuchen F, Tabary S, Giocanti-Auregan A
J Clin Med
. 2022 Feb;
11(3).
PMID: 35159984
Our aim in this study was to assess the vessel density (VD) and vessel skeleton density (VSD) in the nasal area of the superficial capillary plexus (SCP) of diabetic subjects...
10.
Pinto M, Mathis T, Massin P, Akesbi J, Lereuil T, Voirin N, et al.
Pharmaceutics
. 2021 Feb;
13(2).
PMID: 33535719
The purpose of this study is to evaluate the visual acuity (VA) gain profiles between patients with drug-naive diabetic macular edema (DME) treated by dexamethasone implant (DEX-implant) and assess the...